{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:13:09Z","timestamp":1768291989439,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Herscot Center for Tuberous Sclerosis Complex"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.eplepsyres.2015.02.008","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T03:20:40Z","timestamp":1424056840000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex"],"prefix":"10.1016","volume":"112","author":[{"given":"Alexandra L.","family":"Geffrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia D.","family":"Belt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan L.","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/08830738060210011201","article-title":"Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial","volume":"21","author":"Collins","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.12213","article-title":"Development of lacosamide for the treatment of partial-onset seizures","volume":"1291","author":"Doty","year":"2013","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nurt.2006.10.002","article-title":"Lacosamide","volume":"4","author":"Doty","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0030","first-page":"87","article-title":"Topiramate as therapy for tuberous sclerosis complex-associated seizures","volume":"41","author":"Franz","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0035","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1528-1157.2001.042007935.x","article-title":"Lamotrigine therapy of epilepsy in tuberous sclerosis","volume":"42","author":"Franz","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.eplepsyres.2012.10.010","article-title":"Clobazam therapy of refractory epilepsy in tuberous sclerosis complex","volume":"104","author":"Jennesson","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0045","series-title":"Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics","author":"Kwiatkowski","year":"2010"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pedhc.2006.05.004","article-title":"Tuberous sclerosis complex: a review","volume":"21","author":"Leung","year":"2007","journal-title":"J. Pediatr. Health Care"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0055","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1177\/0883073807307093","article-title":"Intrafamilial phenotypic variability in tuberous sclerosis complex","volume":"22","author":"Lyczkowski","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0060","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: a U.S. consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0065","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.eplepsyres.2014.06.018","article-title":"Adjunctive lacosamide\u20145 years\u2019 clinical experience","volume":"108","author":"Stephen","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.02.008_bib0070","article-title":"Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide","author":"Wilson","year":"2014","journal-title":"Mol. Neurobiol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:32:45Z","timestamp":1760275965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121115000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":14,"alternative-id":["S0920121115000273"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.02.008","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}